Risk factors
Pfizer (PFE) risk factors
Item 1A of every Pfizer Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors18 risks3 new1 dropped11 reworded
OBBBA healthcare funding cuts could increase pricing controls and reduce demand, with CBO estimating 10 million more uninsured people.
Filed Feb 26, 2026 - FY2024 10-K risk factors16 risks
Pfizer faces heavy exposure to pricing pressure from biosimilars and government price controls under U.S. and international regulations. The company relies heavily on third-party collaborators and complex supply chains for manufacturing and distribution. Pipeline development carries high clinical trial risks alongside substantial intangible asset and intellectual property exposures.
Filed Feb 27, 2025